Vivani Medical VANI Biopharm Division — Operating Expenses

Other segment segments

Similar metrics at other companies

ANABBiopharma Company — Operating Expenses

$52.81M+3.0%

NAG

NAGEPharmaceuticals segment — Operating Expenses

$468K+27.2%

LHBiopharma Laboratory Services — Other Cost and Expense, Operating

$89.7M-0.3%

MANETotal Operating Expenses

$29.86M+131%

PFEBiopharma — Selling, informational and administrative expenses

$2.13B-2.5%

VCYTBiopharmaceutical and other revenue — Other cost

$8K-99.2%

Questions, answered.

What is Vivani Medical's biopharm division — operating expenses?

Vivani Medical (VANI) reported biopharm division — operating expenses of $6M in Q1 2026.

How has Vivani Medical's biopharm division — operating expenses changed year-over-year?

Vivani Medical's biopharm division — operating expenses decreased by 0.0% year-over-year, from $6M to $6M.

What does biopharm division — operating expenses mean?

Represents the total costs incurred by the biopharmaceutical business segment to support its core research, development, and administrative activities. This metric captures the operational burn rate required to advance drug candidates through preclinical stages. Monitoring this helps investors assess the efficiency of resource allocation within the segment's drug development pipeline.